None listed
Conditions
Brief summary
Upper gastrointestinal endoscopy is commonly performed procedure for the diagnostic approach of gastrointestinal diseases. Authors design a randomized clinical trial with adult patients who required a diagnostic upper gastrointestinal endoscopy, to compare the anxiety score, in the interventional vs control group, 30 minutes post nasal endoscopy procedure. In the intervention and control group a brief explanation before the nasal endoscopy procedure, with video images and audio-guided description will be reproduced. In addition, the intervention group, a second video with images and audio that stimulates patient relaxation, will be reproduced during the nasal endoscopic procedure. The study hypothesis is relaxation video and images effectively decreases the anxiety in patients who undergo nasal endoscopy.
Interventions
A video consisting of various images and audio that stimulates patient relaxation will be reproduced by the operator and co-investigator of the study, during the nasal endoscopic procedure, which lasts around 40 minutes.
For the reproduction of the video, a virtual reality viewer, called Oculus Go (Facebook Technologies, LLC), will be used, in addition to hearing aids with surround sound. The video and sound content were created with copyright-free audiovisual material, in which landscape images
A video consisting of various images and audio that stimulates patient relaxation will be reproduced by the operator and co-investigator of the study, during the nasal endoscopic procedure, which lasts around 40 minutes. For the reproduction of the video, a virtual reality viewer, called Oculus Go (Facebook Technologies, LLC), will be used, in addition to hearing aids with surround sound. The video and sound content were created with copyright-free audiovisual material, in which landscape images and relaxation music are played throughout the whole procedure. Also, the explanation video will be reproduced before the nasal endoscopy procedure.
Sponsors
Hospital Universitario, Dr. José E. González, Universidad Autónoma de Nuevo León
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Patients with the following criteria will be included in the study: Male or female, 18-65 years of age, Globus, Symptomatology of chronic refractory reflux to pharmacological therapy, Dyspeptic syndrome without alarm data, Non-cardiac chest pain.
Exclusion criteria
Patients with the following criteria will be excluded from the study: Dysphagia, Alarm signs (weight loss, etc.), History of food impact, Previous use of aspirin or anticoagulants (3 months), History of recurrent epistaxis, History of nasal trauma, Chronic sinusitis, Previous nasal surgeries, Highly anxious patients.
Outcome results
None listed